Articles tagged "Echocardiography"

2022 American Transplant Congress
Less is More. Extensive Cardiac Investigations Add Little Value in Waitlisting Patients for Kidney Transplantation
B. Chow¹, M. Khurram², E. Capuano², F. Pugliese², M. Yaqoob², I. Mohamed²
¹Barts and the London School of Medicine and Dentistry, London, United Kingdom, ²Department of Renal and Transplantation, Royal London Hospital, Bart's Health NHS Trust, London, United Kingdom
*Purpose: Extensive cardiac investigations have long been considered necessary to aid decision-making in waitlisting for kidney transplantation. However, the utility and reliability of such comprehensive…
2022 American Transplant Congress
Cardiovascular Assessment After Kidney Transplantation in Children and Adolescents
J. Liu, L. Zhang, X. Li, L. Zhu, Y. Lin, X. He, L. Liu, J. Li, C. Wang, S. Li
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: End-stage renal disease is often accompanied by cardiovascular events, and cardiovascular events still exist after kidney transplantation. Cardiovascular disease is the main cause of…
2022 American Transplant Congress
Changes in Diastolic Function and Cardiac Geometry After Pediatric Kidney Transplant: A Longitudinal Study
K. Sgambat¹, S. Clauss², A. Moudgil¹
¹Nephrology, Children's National Hospital, Washington DC, DC, ²Cardiology, Children's National Hospital, Washington DC, DC
*Purpose: Kidney transplant recipients are at increased risk for cardiovascular disease but systolic function is often preserved and may not reveal cardiac dysfunction until it…
2022 American Transplant Congress
Impact of Kidney Transplant on Post-Operative Morbidity and Mortality in Patients with Pre-Existing Cardiac Conditions (Low Ejection Fraction): A Case Series
A. Kumar, C. Naso, D. Bacon, D. Gerber
Abdominal Transplant Surgery, UNC School of Medicine, Chapel Hill, NC
*Purpose: Patients with underlying cardiac diseases have higher morbidity and mortality as compared to the patients without any cardiac diseases. There has been a number…
2022 American Transplant Congress
Evolution of Pretransplant Cardiac Risk Factor Burden and Major Adverse Cardiovascular Events in Liver Transplant Recipients Over Time
C. Harrington, P. Levy, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner
Northwestern Medicine, Chicago, IL
*Purpose: The aim of this study is to evaluate the evolution of MACE and pre-LT cardiac risk factors in LTRs over time.*Methods: This is a…
2021 American Transplant Congress
The Utility of PET/ CT Testing in Cardiac Risk Stratification of Adult Liver Transplant Candidates
M. A. Tincopa¹, R. Weinberg¹, S. Sengupta¹, J. Slivnick², J. Corbett¹, C. Sonnenday¹, R. Fontana¹, P. Sharma¹
¹Internal Medicine, University of Michigan, Ann Arbor, MI, ²Internal Medicine, Ohio State University, Columbus, OH
*Purpose: Optimal cardiovascular (CV) risk stratification in liver transplant (LT) candidates remains unclear. The aim of this study was to assess concordance and utility of…
2021 American Transplant Congress
Peri-operative Liver Transplant Anesthesia Practice Patterns in the United States
C. Crouch¹, A. Hendrickse¹, W. Stoll², C. Sullivan³, M. Kaufman⁴, E. Pivalizza⁵, D. Damian⁶, D. Sellers⁷, M. Little⁸, S. McCluskey⁷, S. Kumar⁹, L. De Marchi¹⁰, S. Sridhar⁵, T. Sakai⁶
¹Department of Anesthesiology, University of Colorado, Aurora, CO, ²Medical University of South Carolina, Charleston, SC, ³Emory University, Atlanta, GA, ⁴Lahey Health, Burlington, MA, ⁵University of Texas Health Science Center at Houston, Houston, TX, ⁶University of Pittsburgh, Pittsburgh, PA, ⁷University of Toronto, Toronto, ON, Canada, ⁸University of Texas Health Science Center San Antonio, San Antonio, TX, ⁹University of Michigan, Ann Arbor, MI, ¹⁰Georgetown University, Washington DC, DC
*Purpose: Transplant anesthesiology is an evolving subspecialty and has not been the subject of an overall review of practice patterns in the United States since…
2021 American Transplant Congress
Right Ventricular Dysfunction After Heart Transplantation: When to Worry?
S. Kim, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, R. Skorka, D. Chang, E. Kransdorf, M. Hamilton, B. Azarbal, L. Czer, D. Ramzy, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Right ventricular (RV) dysfunction after heart transplantation (HTx) is not uncommon. The cause of RV dysfunction may be due to inadequate preservation, high pulmonary…
2021 American Transplant Congress
Kidney Transplantation in Patients with Severe Pulmonary Hypertension: Not an Absolute Contraindication?
B. Prajapati¹, D. Gumber², I. Moinuddin¹, C. Bhati¹, G. Gupta¹, D. Grinnan³, D. Kumar¹
¹Nephrology, Virginia Commonwealth University, Richmond, VA, ²Cardiology, Virginia Commonwealth University, Richmond, VA, ³Pulmonology, Virginia Commonwealth University, Richmond, VA
*Purpose: Severe pulmonary arterial hypertension (PAH) as defined by a pulmonary artery systolic pressure (PASP) >50mmHg is associated with high peri-operative mortality and thus is…
2021 American Transplant Congress
Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure
H. Mogallapalli
Department of Medicine, University of Wisconsin-Madison, Madison, WI
*Purpose: Calcineurin inhibitors (CNI) exert deleterious effect on cardiovascular risk in kidney transplant recipients (KTRs). Belatacept conversion may reduce CV risk in KTRs. We hypothesized…